[Primary hypertriglyceridemia]

Area of Science:

• Genetics and Molecular Biology
• Metabolic Disorders
• Cardiovascular Disease Risk Factors

Context:

• Familial hypertriglyceridemia (FHTG) is a common inherited lipid disorder.
• The genetic basis for FHTG remains incompletely understood.
• Lipoprotein lipase (LPL) gene and apolipoprotein gene clusters are potential candidates.

Purpose:

• To investigate the genetic and metabolic factors contributing to familial hypertriglyceridemia.
• To elucidate the primary drivers of hypertriglyceridemia in affected families.
• To understand the interplay between VLDL-TG production, LPL activity, and insulin sensitivity.

Summary:

• Heterozygous LPL deficiencies can cause mild to moderate hypertriglyceridemia due to impaired VLDL catabolism.
• However, increased VLDL-TG production appears to be a more significant factor than LPL deficiency alone.
• Impaired insulin sensitivity and hyperinsulinemia are strongly linked to excessive VLDL-TG synthesis, driving FHTG.
• While VLDL-TG overproduction is the major cause, VLDL clearance capacity influences the severity of triglyceride elevation.

Impact:

• Identifies VLDL-TG overproduction as the primary mechanism in FHTG.
• Highlights the critical role of insulin resistance and hyperinsulinemia in dyslipidemia.
• Provides insights into the complex pathophysiology of familial hypertriglyceridemia.
• Suggests potential therapeutic targets focusing on VLDL-TG synthesis and clearance pathways.